Alx Oncology Holdings (ALXO) Accumulated Depreciation (2019 - 2026)

Alx Oncology Holdings has reported Accumulated Depreciation for 8 years, with the latest figure at $2.1 million in Q1 2026.

• Quarterly Accumulated Depreciation fell 8.92% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 8.92% YoY) and the FY2025 annual result came in at $2.0 million, down 4.72% from the prior year.
• Accumulated Depreciation rose to $2.1 million in Q1 2026 per ALXO's latest filing, from $2.0 million in the prior quarter.
• Over five years, Accumulated Depreciation peaked at $2.3 million in Q1 2025 and troughed at $121000.0 in Q1 2022.
• A 5-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Accumulated Depreciation.
• The sharpest annual moves came in 2022 and 2026: Accumulated Depreciation jumped 669.23% in 2022, then dropped 8.92% in 2026.
• Over 5 years, Accumulated Depreciation stood at $403000.0 in 2022, then surged by 206.95% to $1.2 million in 2023, then surged by 67.91% to $2.1 million in 2024, then decreased by 4.72% to $2.0 million in 2025, then increased by 5.31% to $2.1 million in 2026.
• According to Business Quant data, Accumulated Depreciation over the past three periods registered $2.1 million, $2.0 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.